Account GLP-1R agonist 15
- Catalog No. :
- ACIYWK348
- CAS No. :
- 2763621-11-8
- Molecular Formula :
- C46H47FN8O7S
- Molecular Weight :
- 875.00
IUPAC Name:3-(1-(2-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(3-(4-((methylsulfonyl)methyl)phenyl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-5-(tetrahydro-2H-pyran-4-yl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | GLP-1R agonist 15 |
|---|---|
| IUPAC Name | 3-(1-(2-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(3-(4-((methylsulfonyl)methyl)phenyl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-5-(tetrahydro-2H-pyran-4-yl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one |
| Molecular Formula | C46H47FN8O7S |
| Molecular Weight | 875.00 |
| SMILES | CC1=C(F)C(C)=CC(N2N=C3CCN(C(=O)C4=CC5=C(C=CC(C6CCOCC6)=C5)N4C4(C5=NOC(=O)N5)CC4C)C(C)C3=C2N2C=CN(C3=CC=C(CS(C)(=O)=O)C=C3)C2=O)=C1 |
| InChI Key | FRMMAGHRLXCIQE-UHFFFAOYSA-N |
| Synonym | 1,2,4-Oxadiazol-5(2H)-one, 3-[1-[2-[[3-[2,3-dihydro-3-[4-[(methylsulfonyl)methyl]phenyl]-2-oxo-1H-imidazol-1-yl]-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-(tetrahydro-2H-pyran-4-yl)-1H-indol-1-yl]-2-methylcyclopropyl]-;GLP-1R agonist 15 |
| CAS No. | 2763621-11-8 |
Synthetic Route by SureRoute
2. ACIYWK348 Molecular Building Block Synthetic Route
3-((1S,2S)-1-(5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl
3-((1S,2S)-1-(5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one calcium salt hydrate (2:1:2)
3-((1S,2S)-1-(2-((S)-3-(3-(4-(diethylphosphoryl)-3-(methylamino)phenyl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-5-(tetrahydro-2H-pyran-4-yl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one